Disturbed Plasma Lipidomic Profiles in Females with Diffuse Large B-Cell Lymphoma: A Pilot Study
暂无分享,去创建一个
L. Bindila | Z. Cvetković | J. Post | R. Masnikosa | V. Vučić | S. Petrovic | Marija Paunović | D. Pirić | Romana Masnikosa | David Pirić | Julia Maria Post | Zorica Cvetković | Snježana Petrović | Marija Paunović | Vesna Vučić | Laura Bindila | S. Petrović
[1] L. Estevinho,et al. Oxidative Stress and Inflammation in B-Cell Lymphomas , 2023, Antioxidants.
[2] K. Young,et al. Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma , 2023, International journal of molecular sciences.
[3] L. Bindila,et al. Four-dimensional trapped ion mobility spectrometry lipidomics for high throughput clinical profiling of human blood samples , 2023, Nature Communications.
[4] Feng Cheng,et al. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer , 2023, Analytical and Bioanalytical Chemistry.
[5] Peng Liu,et al. COX-2/PGE2 upregulation contributes to the chromosome 17p-deleted lymphoma , 2023, Oncogenesis.
[6] A. Llorente,et al. Lipid Biomarkers in Liquid Biopsies: Novel Opportunities for Cancer Diagnosis , 2023, Pharmaceutics.
[7] Yanhua Yue,et al. Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab , 2023, Annals of Hematology.
[8] D. Hodson,et al. Genetic Profiling in Diffuse Large B Cell Lymphoma – the promise and the challenge , 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[9] S. Benitah,et al. The role of lipids in cancer progression and metastasis. , 2022, Cell metabolism.
[10] U. Vitolo,et al. Treatment strategies for patients with diffuse large B-cell lymphoma. , 2022, Cancer treatment reviews.
[11] E. Steliarova-Foucher,et al. Global patterns of non‐Hodgkin lymphoma in 2020 , 2022, International journal of cancer.
[12] Yang Zhang,et al. Metabolic detection of malignant brain gliomas through plasma lipidomic analysis and support vector machine-based machine learning , 2022, EBioMedicine.
[13] Xia Li,et al. Plasma lipids signify the progression of precancerous gastric lesions to gastric cancer: a prospective targeted lipidomics study , 2022, Theranostics.
[14] R. Flavin,et al. Molecular Diagnostic Review of Diffuse Large B-Cell Lymphoma and Its Tumor Microenvironment , 2022, Diagnostics.
[15] P. Morales,et al. The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling. , 2022, Life sciences.
[16] B. Lutz,et al. Lipidomics and Transcriptomics in Neurological Diseases. , 2022, Journal of visualized experiments : JoVE.
[17] Y. Miki,et al. Secreted phospholipase A2 modifies extracellular vesicles and accelerates B cell lymphoma. , 2022, Cell metabolism.
[18] B. Melichar,et al. Lipidomic profiling of human serum enables detection of pancreatic cancer , 2022, Nature Communications.
[19] S. Gerber,et al. Long‐term molecular differences between resilient and susceptible mice after a single traumatic exposure , 2021, British journal of pharmacology.
[20] Yayi Hou,et al. Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies. , 2021, Genes & diseases.
[21] N. Urban,et al. Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass , 2021, Scientific Reports.
[22] B. Melichar,et al. Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls , 2021, Scientific Reports.
[23] S. Ghil,et al. Interactions between lysophosphatidylinositol receptor GPR55 and sphingosine-1-phosphate receptor S1P5 in live cells. , 2021, Biochemical and biophysical research communications.
[24] J. Walia,et al. A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis , 2021, International journal of molecular sciences.
[25] J. Swinnen,et al. Lipid metabolism in cancer: New perspectives and emerging mechanisms. , 2021, Developmental cell.
[26] P. Meikle,et al. Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer , 2021, Prostate Cancer and Prostatic Diseases.
[27] S. Barta,et al. 2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management , 2021, American journal of hematology.
[28] L. Sehn,et al. Diffuse Large B-Cell Lymphoma. , 2021, The New England journal of medicine.
[29] X. Zhong,et al. Upregulation of fatty acid synthase in MYC and BCL-2 double-expressor lymphoma , 2021, Oncology letters.
[30] Prashanth Rawla,et al. Epidemiology of Non-Hodgkin’s Lymphoma , 2021, Medical sciences.
[31] L. Qin,et al. Lipid metabolism in cancer progression and therapeutic strategies , 2020, MedComm.
[32] T. Uehara,et al. Serum sphingomyelin species profile is altered in hematologic malignancies. , 2020, Clinica chimica acta; international journal of clinical chemistry.
[33] Yong Li,et al. Targeting of the Alox12-12-HETE in Blast Crisis Chronic Myeloid Leukemia Inhibits Leukemia Stem/Progenitor Cell Function , 2020, Cancer management and research.
[34] Long N Nguyen,et al. Emerging roles of lysophospholipids in health and disease. , 2020, Progress in lipid research.
[35] S. Bojesen,et al. Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals , 2020, Journal of Hematology & Oncology.
[36] Feng Cheng,et al. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer. , 2020, Life sciences.
[37] S. Pyne,et al. Recent advances in the role of sphingosine 1‐phosphate in cancer , 2020, FEBS letters.
[38] J. Hui,et al. High-coverage plasma lipidomics reveals novel sex-specific lipidomic fingerprints of age and BMI: Evidence from two large population cohort studies , 2020, PLoS biology.
[39] Philip C. Calder. Eicosanoids. , 2020, Essays in biochemistry.
[40] Wei Guo,et al. Function and regulation of lipid signaling in lymphomagenesis: A novel target in cancer research and therapy. , 2020, Critical reviews in oncology/hematology.
[41] D. Balgoma,et al. Lipidomic-Based Advances in Diagnosis and Modulation of Immune Response to Cancer , 2020, Metabolites.
[42] D. Ribatti,et al. Inflammatory Cells in Diffuse Large B Cell Lymphoma , 2020, Journal of clinical medicine.
[43] M. Loda,et al. Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. , 2020, Advanced drug delivery reviews.
[44] M. Maccarrone,et al. Bioactive lipids, inflammation and chronic diseases. , 2020, Advanced drug delivery reviews.
[45] Nikos Koundouros,et al. Reprogramming of fatty acid metabolism in cancer , 2019, British Journal of Cancer.
[46] Ke Xu,et al. Roles of sphingosine-1-phosphate signaling in cancer , 2019, Cancer Cell International.
[47] G. Fairn,et al. Distribution, dynamics and functional roles of phosphatidylserine within the cell , 2019, Cell Communication and Signaling.
[48] K. Young,et al. Genetic alterations and their clinical implications in DLBCL , 2019, Nature Reviews Clinical Oncology.
[49] Jong Cheol Lee,et al. Plasma lipid profile comparison of five different cancers by nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry. , 2019, Analytica chimica acta.
[50] B. Lutz,et al. Broad Lipidomic and Transcriptional Changes of Prophylactic PEA Administration in Adult Mice , 2019, Front. Neurosci..
[51] É. Boilard,et al. Roles of secreted phospholipase A2 group IIA in inflammation and host defense. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[52] Yang Hao,et al. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data , 2019, BMC Bioinformatics.
[53] M. Care,et al. Sphingosine-1-phosphate Signalling drives an Angiogenic Transcriptional Programme in Diffuse Large B Cell Lymphoma , 2019, Leukemia.
[54] W. Gu,et al. ALOX12 is required for p53-mediated tumor suppression through a distinct ferroptosis pathway , 2019, Nature Cell Biology.
[55] J. Shaw,et al. High-Throughput Plasma Lipidomics: Detailed Mapping of the Associations with Cardiometabolic Risk Factors. , 2019, Cell chemical biology.
[56] M. Najafi,et al. Cyclooxygenase‐2 in cancer: A review , 2018, Journal of cellular physiology.
[57] S. Dudoit,et al. Untargeted lipidomic features associated with colorectal cancer in a prospective cohort , 2018, BMC Cancer.
[58] Xiangjian Luo,et al. The implications of signaling lipids in cancer metastasis , 2018, Experimental & Molecular Medicine.
[59] Jian-yong Li,et al. Low serum cholesterol levels predict inferior prognosis and improve NCCN‐IPI scoring in diffuse large B cell lymphoma , 2018, International journal of cancer.
[60] K. Sakimura,et al. Different Roles of Sphingosine Kinase 1 and 2 in Pancreatic Cancer Progression. , 2018, The Journal of surgical research.
[61] T. Wakai,et al. Expression of phosphorylated sphingosine kinase 1 is associated with diffuse type and lymphatic invasion in human gastric cancer , 2018, Surgery.
[62] E. A. Hafez,et al. Synopsis of arachidonic acid metabolism: A review , 2018, Journal of advanced research.
[63] A. Beheshti,et al. Fatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL , 2018, Nature Communications.
[64] M. Eberlin,et al. Plasma Lipidomic Signature of Rectal Adenocarcinoma Reveals Potential Biomarkers , 2018, Front. Oncol..
[65] Beat Lutz,et al. Simultaneous lipidomic and transcriptomic profiling in mouse brain punches of acute epileptic seizure model compared to controls[S] , 2017, Journal of Lipid Research.
[66] N. Hait,et al. The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer , 2017, Mediators of inflammation.
[67] Youping Deng,et al. Global lipidomics identified plasma lipids as novel biomarkers for early detection of lung cancer , 2017, Oncotarget.
[68] R. Epand. Features of the Phosphatidylinositol Cycle and its Role in Signal Transduction , 2016, The Journal of Membrane Biology.
[69] C. Chalfant,et al. Lipidomics in translational research and the clinical significance of lipid-based biomarkers. , 2017, Translational research : the journal of laboratory and clinical medicine.
[70] J. Idle,et al. The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features , 2017, BBA clinical.
[71] B. Lutz,et al. Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[72] M. Shipp,et al. Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets , 2016, Cell Death and Differentiation.
[73] T. Wakai,et al. High levels of sphingolipids in human breast cancer. , 2016, The Journal of surgical research.
[74] Youping Deng,et al. Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions , 2016, Oncotarget.
[75] L. Brown,et al. International long‐term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0–19 years , 2016, International journal of cancer.
[76] N. Schultz,et al. Deletions linked to TP53 loss drive cancer through p53-independent mechanisms , 2016, Nature.
[77] S. Beloribi-Djefaflia,et al. Lipid metabolic reprogramming in cancer cells , 2016, Oncogenesis.
[78] B. Levy,et al. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation , 2015, Nature Reviews Immunology.
[79] R. Tibshirani,et al. Alteration of the lipid profile in lymphomas induced by MYC overexpression , 2014, Proceedings of the National Academy of Sciences.
[80] David Dunson,et al. Genetic heterogeneity of diffuse large B-cell lymphoma , 2013, Proceedings of the National Academy of Sciences.
[81] Michael R. Green,et al. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. , 2012, Cancer cell.
[82] Eoin Fahy,et al. Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.
[83] M. Glibetić,et al. Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma , 2010, Annals of Hematology.
[84] A. Porwit,et al. Hodgkin Reed–Sternberg cells express 15‐lipoxygenase‐1 and are putative producers of eoxins in vivo , 2008, The FEBS journal.
[85] A. Shevchenko,et al. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. , 2008, Journal of lipid research.
[86] Tonya S. King,et al. Sphingosine kinase 1 protein and mRNA are overexpressed in non-Hodgkin lymphomas and are attractive targets for novel pharmacological interventions , 2008, Leukemia & lymphoma.
[87] R. Gascoyne,et al. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. , 2007, Blood.
[88] K. Al-Kuraya,et al. Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival. , 2005, Blood.
[89] M. Ergin,et al. Cyclooxygenase-2 (Cox-2) Expression in Lymphomas , 2004, Leukemia & lymphoma.
[90] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[91] M Tubiana,et al. Report of the Committee on Hodgkin's Disease Staging Classification. , 1971, Cancer research.
[92] Z. Xu-Monette,et al. Prognostic and therapeutic value of serum lipids and a new IPI score system based on apolipoprotein A-I in diffuse large B-cell lymphoma. , 2023, American journal of cancer research.
[93] Xianlin Han,et al. Lipid Metabolism and Lipidomics Applications in Cancer Research. , 2021, Advances in experimental medicine and biology.
[94] Y. Miki,et al. Secreted Phospholipase A2 Specificity on Natural Membrane Phospholipids. , 2017, Methods in enzymology.
[95] M. Falasca,et al. Role of the lysophosphatidylinositol/GPR55 axis in cancer. , 2016, Advances in biological regulation.
[96] J. Cerhan,et al. Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. , 2014, Journal of the National Cancer Institute. Monographs.
[97] F. Lansigan,et al. FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma , 2012, Journal of Hematopathology.
[98] Robert Tibshirani,et al. A comparison of fold-change and the t-statistic for microarray data analysis , 2007 .
[99] T. Uchiyama,et al. Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.